Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1951 1
1952 5
1953 2
1954 1
1956 1
1957 3
1958 1
1960 1
1961 1
1963 3
1965 4
1966 4
1968 7
1969 4
1970 5
1971 11
1972 6
1973 5
1974 9
1975 12
1976 13
1977 18
1978 15
1979 15
1980 23
1981 10
1982 26
1983 22
1984 24
1985 22
1986 27
1987 27
1988 32
1989 47
1990 41
1991 46
1992 52
1993 72
1994 78
1995 72
1996 75
1997 65
1998 69
1999 107
2000 98
2001 95
2002 126
2003 138
2004 142
2005 162
2006 225
2007 211
2008 200
2009 194
2010 232
2011 238
2012 224
2013 249
2014 288
2015 318
2016 281
2017 283
2018 290
2019 299
2020 329
2021 345
2022 281
2023 280
2024 114

Text availability

Article attribute

Article type

Publication date

Search Results

6,110 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Hagensieker
Page 1
Dedication to Ron Pace.
Dismukes GC, Stranger R, Smith P. Dismukes GC, et al. Photosynth Res. 2022 May;152(2):95-96. doi: 10.1007/s11120-022-00928-5. Photosynth Res. 2022. PMID: 35759129
Ron Pace (6 July 1946 to 4 January 2021) was a scientist of deep intellectual pursuits, an eager debater of the laws of nature, and an admired teacher, whose generous character and humorous spirit was a gift to his colleagues, collaborators, and students....
Ron Pace (6 July 1946 to 4 January 2021) was a scientist of deep intellectual pursuits, an eager debater of the laws of nature, and a …
Mentors: Ron Kaback.
Carrasco N. Carrasco N. J Gen Physiol. 2019 Feb 4;151(2):97-99. doi: 10.1085/jgp.201912322. Epub 2019 Jan 23. J Gen Physiol. 2019. PMID: 30674562 Free PMC article.
Carrasco reflects on her postdoctoral advisor, Ron Kaback-an exceptional scientist and inspiring mentor....
Carrasco reflects on her postdoctoral advisor, Ron Kaback-an exceptional scientist and inspiring mentor....
RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence.
Hunt BG, Davis JC, Fox LH, Vicente-Muñoz S, Lester C, Wells SI, Waltz SE. Hunt BG, et al. Oncogene. 2023 May;42(21):1716-1727. doi: 10.1038/s41388-023-02688-5. Epub 2023 Apr 7. Oncogene. 2023. PMID: 37029299 Free PMC article.
RON directed therapies are in development, but preclinical data directly testing the impact of RON inhibition on metastatic progression/recurrence are lacking, and mechanisms to exert this function remain unclear. ...RON promoted mammosphere formation through …
RON directed therapies are in development, but preclinical data directly testing the impact of RON inhibition on metastatic pr …
Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy.
Kim J, Koh DI, Lee M, Park YS, Hong SW, Shin JS, Lee MS, Kim MH, Lee JH, Jeong J, Bae S, Hong JK, Jeong HR, Ryu YS, Kim SM, Choi M, Kim H, Ryu H, Hur SC, Park J, Hur DY, Jin DH. Kim J, et al. Cell Death Differ. 2023 Dec;30(12):2491-2507. doi: 10.1038/s41418-023-01235-9. Epub 2023 Nov 6. Cell Death Differ. 2023. PMID: 37926711
Also, we elucidated the roles of three splicing variants of RON, RON delta155, delta160, and delta165 as tumor drivers in cancer cell lines. Subsequently, we designed an inhibitor of RON, WM-S1-030, to suppress phosphorylation thereby inhibiting the activatio …
Also, we elucidated the roles of three splicing variants of RON, RON delta155, delta160, and delta165 as tumor drivers in canc …
An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling.
Hunt BG, Fox LH, Davis JC, Jones A, Lu Z, Waltz SE. Hunt BG, et al. Genes (Basel). 2023 Feb 17;14(2):517. doi: 10.3390/genes14020517. Genes (Basel). 2023. PMID: 36833444 Free PMC article. Review.
RON and its ligand HGFL demonstrate cross-talk with other growth receptors and, consequentially, positions RON at the intersection of numerous tumorigenic signaling programs. For this reason, RON is an attractive therapeutic target in cancer research. A bette …
RON and its ligand HGFL demonstrate cross-talk with other growth receptors and, consequentially, positions RON at the intersec …
MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity.
Huang L, Fang X, Shi D, Yao S, Wu W, Fang Q, Yao H. Huang L, et al. Front Immunol. 2020 Oct 7;11:569082. doi: 10.3389/fimmu.2020.569082. eCollection 2020. Front Immunol. 2020. PMID: 33117355 Free PMC article. Review.
Another study provided evidence of the relationship between MSP-RON and autoimmune diseases, suggesting a potential role for MSP-RON in the development of drugs for autoimmune diseases. ...Here, we summarize the role of MSP-RON in immunity, based on recent fi …
Another study provided evidence of the relationship between MSP-RON and autoimmune diseases, suggesting a potential role for MSP-R …
RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets.
Chen SL, Wang GP, Shi DR, Yao SH, Chen KD, Yao HP. Chen SL, et al. World J Gastroenterol. 2021 May 28;27(20):2507-2520. doi: 10.3748/wjg.v27.i20.2507. World J Gastroenterol. 2021. PMID: 34092972 Free PMC article. Review.
The receptor protein tyrosine kinase RON belongs to the c-MET proto-oncogene family. Research has shown that RON has a role in cancer pathogenesis, which places RON on the frontline of the development of novel cancer therapeutic strategies. ...Thus, not only …
The receptor protein tyrosine kinase RON belongs to the c-MET proto-oncogene family. Research has shown that RON has a role in …
The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies.
Cazes A, Childers BG, Esparza E, Lowy AM. Cazes A, et al. Cancers (Basel). 2022 Apr 18;14(8):2037. doi: 10.3390/cancers14082037. Cancers (Basel). 2022. PMID: 35454943 Free PMC article. Review.
The MST1R/RON receptor tyrosine kinase is a homologue of the more well-known MET receptor. ...Tyrosine kinase inhibitors targeting RON have been developed, making RON an actionable therapeutic target....
The MST1R/RON receptor tyrosine kinase is a homologue of the more well-known MET receptor. ...Tyrosine kinase inhibitors targeting …
Ron receptor tyrosine kinase signaling as a therapeutic target.
Benight NM, Waltz SE. Benight NM, et al. Expert Opin Ther Targets. 2012 Sep;16(9):921-31. doi: 10.1517/14728222.2012.710200. Epub 2012 Jul 26. Expert Opin Ther Targets. 2012. PMID: 22834780 Free PMC article. Review.
INTRODUCTION: Since its discovery nearly 20 years ago, the Ron receptor tyrosine kinase has been extensively studied. These studies have elucidated many of the major signaling pathways activated by Ron. In the context of the inflammation and cancer, studies have sho …
INTRODUCTION: Since its discovery nearly 20 years ago, the Ron receptor tyrosine kinase has been extensively studied. These studies h …
Ron Laskey.
Laskey R. Laskey R. Curr Biol. 2015 Apr 20;25(8):R313. doi: 10.1016/j.cub.2015.02.016. Curr Biol. 2015. PMID: 26082955 Free article. No abstract available.
6,110 results